HomeAI · summaries
Storia in 5 fonti
India approves Novo Nordisk’s weight loss drug Wegovy for fatty liver disease
The Central Drugs Standard Control Organization (CDSCO) has approved Danish major Novo Nordisk’s weight loss drug Wegovy (semaglutide injection 2.4 mg) for a new indication — fatty liver disease.
Confronto fonti
5 prospettive sulla stessa storiaTimeline cronologica
- ·
open.online
Semaglutide in pillole, via libera dell’Ue al primo GLP-1 orale per la gestione del peso
Autorizzata la prima versione in compresse di un farmaco della famiglia dei GLP-1 destinato alla gestione del peso
- ·
economictimes.indiatimes.com
Novo Nordisk's obesity drug Wegovy wins India approval to fight silent fatty liver killer
India's drug regulator approved Novo Nordisk's Wegovy for MASH treatment. This drug targets a serious progressive form of fatty liver disease. The approval follows a committee…
